Activated ERK1/2 has been shown to decrease chemokine mRNA stability and decrease chemokine mRNA expression, suggesting that EGFR-dependent ERK1/2 activity in keratinocytes also participates in homeostatic mechanisms that regulate dermatitis response [31]. The gene discussed is EGFR; the disease is skin disorder.